Advances in Immunotherapy in Esophagogastric Cancer

Hematology/Oncology Clinics of North America（2024）

引用 0|浏览0

暂无评分

摘要

Immune checkpoint inhibitors are rapidly transforming the care of patients with esophagogastric cancer. Particularly, anti-PD-1 therapy has demonstrated promising efficacy in metastatic and resectable disease. In this review, the authors discuss landmark clinical trials, highlight challenges and opportunities in this field, and propose potential directions for future work.

查看译文

关键词

Immunotherapy,Immune checkpoint inhibitor,PD-1,PD-L1,Esophageal,Gastroesophageal,Cancer,Malignancy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要